Genomics Market Global Industry Analysis 2024 - 2031 | Thermo Fisher Scientific, Inc., Agilent Technologies

Market Overview:

Genomics is the study of genomes through genome sequencing and genetic analyses to access the complete set of DNA within a given species. Technologies such as next generation sequencing and microarray are used to understand and diagnosis diseases at the genetic level to develop personalized medicine.

Market Dynamics:

The genomics market is expected to witness significant growth over the forecast period owing to two key drivers. Firstly, precision medicine is gaining traction due to its ability to customize treatment and care based on individual patient's genetic makeup and traits. Genomic data helps in understanding disease pathogenesis at molecular level and identifying therapeutic targets. Secondly, declining costs of genome sequencing technologies along with high throughput capabilities are supporting genomic research activities and discoveries. This is supporting application of genomics in clinical diagnosis and drug development processes. Moreover, increasing collaborations between pharmaceutical companies and genomic firms to integrate genomic insights in drug development also supports market growth over the forecast period.

Get a Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2660

Major Keyplayers Included in the Report:

Thermo Fisher Scientific, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Illumina, Inc., Pacific Biosciences, Oxford Nanopore Technologies., 23andMe, Inc., Foundation Medicine, Inc. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

Major Market Drivers for Genomics Market

Rising Focus on Personalized Medicine is Driving the Genomics Market

Personalized medicine uses a person's genetic makeup and profile to prevent, diagnose, and treat diseases. With the help of genomics, medical practitioners can now tailor medical treatment to an individual's specific genetic makeup. This significantly improves clinical outcomes and lowers healthcare costs compared to traditional one-size-fits-all approaches. The growing adoption of personalized medicine is propelling greater usage of genomics technologies and services to understand patients' genetic predispositions and tailor their treatment accordingly.

Increasing Incidence of Cancer and other Chronic Diseases is Fueling Genomics Adoption

Chronic diseases, especially cancer, pose a major global healthcare challenge. The high and rising prevalence of different types of cancer and other chronic conditions like diabetes, cardiovascular diseases etc. is driving demand for advanced diagnostic and treatment approaches. Genomics is playing a key role in oncology by enabling better cancer screening, classification of tumor subtypes, selection of targeted therapies, and monitoring of cancer recurrence or progression. It is also helping develop customized treatment plans based on a person's genetic risk factors for chronic diseases. This factor is significantly boosting investments in genomics research and services.

Major Market Restrain for Genomics Market

High Cost of Genomics Technologies and Services Restricting Uptake

While genomics is enabling groundbreaking advancements in medicine, its applications and benefits have been slowed down by the high costs associated with genomics technologies, services, and infrastructure requirements. Implementing genomics in diagnosis and treatment increases overall healthcare expenditures significantly. The high capital requirements for setting up genomics laboratories and facilities and recurring operational costs for assays, reagents, and data processing also contribute to the steep pricing of genomics services. This economic restraint prevents widespread adoption of genomics, especially in developing nations with resource constraints. Cost reduction through automation, economies of scale, and next-gen sequencing technologies will help alleviate this restrain over the coming years.

Major Market Opportunity for Genomics Market

Increasing Consumer Interest in Direct-to-Consumer Genomic Testing Presents Opportunities

Direct-to-consumer (DTC) genetic testing has gained immense popularity as it allows consumers to access their genomics data privately without a physician's involvement. DTC tests examine genetic variations that can provide health, trait, and ancestry information directly to the consumer. This exploding consumer interest represents a major growth opportunity as more people opt for DTC tests out of curiosity and to gain health insights. Industry players are launching new types of DTC tests, broadening their applicability beyond rare diseases and oncology. However, adequate regulatory oversight is needed to validate the clinical relevance of results and address privacy issues for maximizing this opportunity.

Major Market Trends in Genomics Market

Advent of Single-Cell Genomics and Spatial Genomics is a Key Emerging Trend

Single-cell genomics analyzes the genome of individual cells to better understand cell heterogeneity, developmental processes, and disease progression at the cellular level. This breakthrough technique provides precision that was previously unattainable using bulk tissue analyses. Similarly, spatial genomics maps genomic alterations in specific regions of tissues to understand the composition and intercellular interactions within tissues. These pathbreaking innovations are allowing deeper investigation of biological systems at an unprecedented resolution. Substantial R&D investments are fueling advancements in single-cell and spatial technologies, highlighting their significance as emerging trends with lucrative growth prospects in the coming decade.

Purchase This Premium Report With Up To 25% OFF @ https://www.coherentmarketinsights.com/insight/buy-now/2660

Table of Contents with Major Points:

Executive Summary

Introduction
Key Findings
Recommendations
Definitions and Assumptions

Market Overview

Definition of Genomics Market
Market Dynamics
Drivers
Restraints
Opportunities
Trends and Developments

Key Insights

Key Emerging Trends
Key Developments Mergers and Acquisition
New Product Launches and Collaboration
Partnership and Joint Venture
Latest Technological Advancements
Insights on Regulatory Scenario
Porters Five Forces Analysis

Qualitative Insights Impact of COVID-19 on Global Genomics Market

Supply Chain Challenges
Steps taken by Government/Companies to overcome this impact
Potential opportunities due to COVID-19 outbreak
Conclusion

Appendix

Data Sources
Abbreviations
Disclaimer
TOC Continued…!

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/2660

Why Choose Coherent Market Insights?

☛ Identified business opportunities - Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.

☛ A clear understanding of your customers - A market report gives company's marketing department an in-depth picture about customers' needs and wants. This knowledge can be used to improve products, prices, and advertising.

☛ Clear data-driven insights - Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Mr Shah

Coherent Market Insights

533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This release was published on openPR.